1-3 of 3
Quiling Shi, MD, PhD
Close
Sort by
Journal Articles

Retrospective Analysis to Correlate Impact of Symptom Burden and Quality of Life to Treatment Outcome with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Chronic Phase

Binsah George, MD, Williams Lori, Quiling Shi, MD PhD, Talha Badar, MBBS,FCPS, Susan O'Brien, MD, Elias Jabbour, MD, Guillermo Garcia-Manero, MD, Nitin Jain, MD, Farhad Ravandi, MBBS, Gautam Borthakur, MD, William Wierda, MD PhD, Charles S. Cleeland, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2014) 124 (21): 4548.
https://doi.org/10.1182/blood.V124.21.4548.4548
Published: 2014
Journal Articles

Fatigue in Chronic Myelogenous Leukemia Patients (pts) Treated with Tyrosine Kinase Inhibitors (TKI),

Aziz Nazha, Loretta A Williams, PhD, RN, Hagop M. Kantarjian, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Janet L Williams, MPH, Alexandra Probst, Susan O'Brien, Elias Jabbour, Alfonso Quintas-Cardama, MD, Quiling Shi, MD, PhD, Charles S Cleeland, PhD, Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 3785.
https://doi.org/10.1182/blood.V118.21.3785.3785
Published: 2011
Journal Articles

Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Loretta A Williams, PhD, RN, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Quiling Shi, MD, PhD, Janet L Williams, MPH, Charles S Cleeland, PhD, Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 3138.
https://doi.org/10.1182/blood.V118.21.3138.3138
Published: 2011